Skip to main content

Decoy Therapeutics Inc.

corporate_fare Company Profile

Decoy Therapeutics Inc.

DCOY·NASDAQ·Life Sciences·CIK 0001615219

Decoy Therapeutics Inc. is a pre-clinical stage biotechnology company focused on developing peptide conjugate therapeutics. The company utilizes its proprietary IMP 3 ACT™ platform, which incorporates machine learning ("ML") and artificial intelligence ("AI") tools with high-speed synthesis techniques. This platform is designed to engineer, optimize, and manufacture peptide conjugates to address unmet medical needs. Decoy Therapeutics aims to build a portfolio of these therapeutics, initially concentrating on infectious diseases and oncology. The company's goal is to become a fully integrated biopharmaceutical company in this field. Decoy Therapeutics has no products approved for commercial sales and has not generated any revenue from product sales. Prior to January 8, 2026, the company was known as Salarius Pharmaceuticals, Inc. ("Salarius"). In November 2025, Salarius completed a merger with Legacy Decoy and raised capital through financings. On January 8, 2026, Salarius changed its name to Decoy Therapeutics Inc.

Decoy Therapeutics Inc. (NASDAQ:DCOY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 22 items for DCOY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-13, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 10/10, with 14 rated 8 or above. Recent SEC coverage for DCOY spans S-3, 10-Q, 424B3, S-1.

Recent high-impact activity:

  • Decoy Files $50M Shelf While Carrying Going-Concern Warning and Nasdaq Delisting Risk
  • Decoy Therapeutics Posts $3.53/Share Loss, Missing $2.59 Estimate
  • Decoy Therapeutics Q3 10-Q: Going Concern, $8.2M Cash, New Nasdaq Delisting Risk
  • Decoy's 2.37M-Share Armistice Resale Registration Goes Effective; Cash Runs to Early 2027
  • Decoy Files S-1 to Register Resale of 2.37 Million Shares Underlying Armistice Warrants

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$12.52M
Diluted EPS
-$129.10
Op. Cash Flow
-$4.83M
Free Cash Flow
-$5.4M
Operating Income
-$12.61M
Cash & Equivalents
$10.71M
Debt / Equity
0.00×
Shares Outstanding
96.97K sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-195909

Short Interest & Short Volume

1.82 days to cover

FINRA reported short interest of 99,728 shares in DCOY as of the October 30, 2026 settlement, a 2.2% increase from the prior period — about 1.8 days to cover at its recent average daily volume. On November 20, 2026, 37.4% of DCOY volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)99,728 shares as of October 30, 2026
Change vs prior period▲ 2.2%
Days to cover1.82 at avg daily volume of 54,726
Daily short volume (FINRA facilities)37.4% of 28,292 shares on November 20, 2026
5-day average short volume63.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Moderate risk

Filing-implied dilution signals for DCOY, detected from its recent SEC filings · based on capital-structure filings through 2026-07-24.

4 shelf registrations

Warrant Exercise Vote Sought · Massive Potential Dilution

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with D →
$0.845 +1.88% today
52-week range · as of 2026-11-13 $0.845 – $16.92
Market cap
$1.98M
Volume
38K (0.7× avg)
3-mo avg 56.5K
Live data · 2026-11-22 12:38 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed DCOY - Latest Insights

DCOY
Nov 13, 2026, 4:45 PM EST
Filing Type: S-3
Importance Score:
8
Price at Filing: $0.9752
Real-time Price: $0.845 info
Change: -$0.1302 (-13%) info
Market Cap: $1.978M info
DCOY
Nov 12, 2026, 6:31 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.06
Real-time Price: $0.845 info
Change: -$0.210 (-20%) info
Market Cap: $1.978M info
DCOY
Nov 12, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $0.845 info
Change: -$0.210 (-20%) info
Market Cap: $1.978M info
DCOY
Oct 16, 2026, 4:07 PM EDT
Filing Type: 424B3
Importance Score:
7
Price at Filing: $1.17
Real-time Price: $0.845 info
Change: -$0.325 (-28%) info
Market Cap: $1.978M info
DCOY
Oct 07, 2026, 4:59 PM EDT
Filing Type: S-1
Importance Score:
7
Price at Filing: $1.60
Real-time Price: $0.845 info
Change: -$0.7536 (-47%) info
Market Cap: $1.978M info
DCOY
Sep 23, 2026, 5:02 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.99
Real-time Price: $0.845 info
Change: -$3.15 (-79%) info
Market Cap: $1.978M info
DCOY
Sep 22, 2026, 12:50 PM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $3.78
Real-time Price: $0.845 info
Change: -$2.93 (-78%) info
Market Cap: $1.978M info
DCOY
Aug 12, 2026, 4:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.60
Real-time Price: $0.845 info
Change: -$2.76 (-77%) info
Market Cap: $1.978M info
DCOY
Jul 27, 2026, 9:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $5.04
Real-time Price: $0.845 info
Change: -$4.20 (-83%) info
Market Cap: $1.978M info
DCOY
Jul 24, 2026, 4:05 PM EDT
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $5.04
Real-time Price: $0.845 info
Change: -$4.20 (-83%) info
Market Cap: $1.978M info
DCOY
Jul 10, 2026, 4:26 PM EDT
Filing Type: S-1
Importance Score:
8
Price at Filing: $5.91
Real-time Price: $0.845 info
Change: -$5.07 (-86%) info
Market Cap: $1.978M info
DCOY
Jun 29, 2026, 6:03 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $12.34
Real-time Price: $0.845 info
Change: -$11.50 (-93%) info
Market Cap: $1.978M info
DCOY
Jun 26, 2026, 8:11 PM EDT
Source: PR Newswire
Importance Score:
10
Price at Filing: $5.90
Real-time Price: $0.845 info
Change: -$5.06 (-86%) info
Market Cap: $1.978M info
DCOY
Jun 12, 2026, 6:54 PM EDT
Filing Type: S-1
Importance Score:
9
Price at Filing: $5.89
Real-time Price: $0.845 info
Change: -$5.05 (-86%) info
Market Cap: $1.978M info
DCOY
Jun 04, 2026, 8:26 AM EDT
Filing Type: DEF 14A
Importance Score:
8
Price at Filing: $8.50
Real-time Price: $0.845 info
Change: -$7.66 (-90%) info
Market Cap: $1.978M info
DCOY
May 08, 2026, 4:51 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $5.72
Real-time Price: $0.845 info
Change: -$4.88 (-85%) info
Market Cap: $1.978M info
DCOY
May 08, 2026, 4:45 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $5.72
Real-time Price: $0.845 info
Change: -$4.88 (-85%) info
Market Cap: $1.978M info
DCOY
Apr 30, 2026, 1:03 PM EDT
Filing Type: 10-K/A
Importance Score:
7
Price at Filing: $5.54
Real-time Price: $0.845 info
Change: -$4.70 (-85%) info
Market Cap: $1.978M info
DCOY
Apr 02, 2026, 9:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $6.18
Real-time Price: $0.845 info
Change: -$5.34 (-86%) info
Market Cap: $1.978M info
DCOY
Mar 31, 2026, 5:05 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $6.14
Real-time Price: $0.845 info
Change: -$5.30 (-86%) info
Market Cap: $1.978M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets